383 related articles for article (PubMed ID: 34445666)
1. The CB
Ji X; Zeng Y; Wu J
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445666
[TBL] [Abstract][Full Text] [Related]
2. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
3. Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice.
Shapiro L; Wong JC; Escayg A
Epilepsia; 2019 Dec; 60(12):2359-2369. PubMed ID: 31758544
[TBL] [Abstract][Full Text] [Related]
4. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy.
Wallace MJ; Blair RE; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2003 Oct; 307(1):129-37. PubMed ID: 12954810
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
6. Progress in brain cannabinoid CB
Jordan CJ; Xi ZX
Neurosci Biobehav Rev; 2019 Mar; 98():208-220. PubMed ID: 30611802
[TBL] [Abstract][Full Text] [Related]
7. The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole-induced seizure severity in Wistar rats.
de Carvalho CR; Hoeller AA; Franco PL; Martini AP; Soares FM; Lin K; Prediger RD; Whalley BJ; Walz R
Epilepsy Res; 2016 Nov; 127():160-167. PubMed ID: 27608434
[TBL] [Abstract][Full Text] [Related]
8. Microglial Cannabinoid CB
Xu K; Wu Y; Tian Z; Xu Y; Wu C; Wang Z
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768668
[TBL] [Abstract][Full Text] [Related]
9. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological actions of cannabinoids.
Pertwee RG
Handb Exp Pharmacol; 2005; (168):1-51. PubMed ID: 16596770
[TBL] [Abstract][Full Text] [Related]
11. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy.
Smolyakova AM; Zagzoog A; Brandt AL; Black T; Mohamed K; Laprairie RB
J Clin Neurophysiol; 2020 Jan; 37(1):15-27. PubMed ID: 31895186
[TBL] [Abstract][Full Text] [Related]
12. Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.
Li Y; Kim J
Neuroscience; 2015 Dec; 311():253-67. PubMed ID: 26515747
[TBL] [Abstract][Full Text] [Related]
13. Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB
Ferrisi R; Ceni C; Bertini S; Macchia M; Manera C; Gado F
Pharmacol Res; 2021 Aug; 170():105607. PubMed ID: 34089867
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of cannabinoid agents in animals.
Chaperon F; Thiébot MH
Crit Rev Neurobiol; 1999; 13(3):243-81. PubMed ID: 10803637
[TBL] [Abstract][Full Text] [Related]
16. Synthetic cannabinoids reduce the inflammatory activity of microglia and subsequently improve neuronal survival in vitro.
Young AP; Denovan-Wright EM
Brain Behav Immun; 2022 Oct; 105():29-43. PubMed ID: 35764268
[TBL] [Abstract][Full Text] [Related]
17. Crystal Structure of the Human Cannabinoid Receptor CB2.
Li X; Hua T; Vemuri K; Ho JH; Wu Y; Wu L; Popov P; Benchama O; Zvonok N; Locke K; Qu L; Han GW; Iyer MR; Cinar R; Coffey NJ; Wang J; Wu M; Katritch V; Zhao S; Kunos G; Bohn LM; Makriyannis A; Stevens RC; Liu ZJ
Cell; 2019 Jan; 176(3):459-467.e13. PubMed ID: 30639103
[TBL] [Abstract][Full Text] [Related]
18. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
19. Behavioral effects of CB2 cannabinoid receptor activation and its influence on food and alcohol consumption.
Onaivi ES; Carpio O; Ishiguro H; Schanz N; Uhl GR; Benno R
Ann N Y Acad Sci; 2008 Oct; 1139():426-33. PubMed ID: 18991890
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptors in microglia of the central nervous system: immune functional relevance.
Cabral GA; Marciano-Cabral F
J Leukoc Biol; 2005 Dec; 78(6):1192-7. PubMed ID: 16204639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
